Equine Antibody Library Construction by Phage Display

Creative Biolabs supports equine antibody phage display library construction for veterinary research, horse-derived reagent development, and projects that need an equine repertoire in a sequence-defined recombinant format. The work can be organized through custom phage display library construction and coordinated with antibody library construction. Depending on the source material and research objective, the project can follow an immune, naive, or designed/semi-synthetic route.

The schematic of a horse. (Creative Biolabs Authorized)

Service at a Glance

Equine Antibody Library Construction by Phage Display service scope
Service Component	Project Scope
Starting Materials	Horse PBMCs, spleen or other approved lymphoid material, RNA, cDNA, or sequence inputs appropriate to the selected route.
Library Formats	scFv or Fab phage display libraries for immune, naive, or designed/semi-synthetic strategies.
Core Construction	Equine-aware variable-region recovery or sequence design, fragment assembly, cloning, phage rescue, and amplification.
QC Options	Insert and frame checks, repertoire-family representation, redundancy, amplification bias, display competence, and optional NGS.
Optional Downstream Screening	Purified-antigen, competitive, subtractive, or cell-based selection with assay-matched binding confirmation.

The route choice is the main technical decision. An immune library aims to capture a repertoire shaped by a defined antigen exposure; a naive library emphasizes broader sampling from non-targeted donors; and a designed route provides greater control over sequence composition when suitable biological material is limited or deliberate diversification is preferred.

Choosing the Right Equine Library Route
Library Route	Best Starting Point	Main Design Priority
Immune equine library	Documented immunization or antigen-exposure history plus B-cell-rich material collected at a relevant time.	Preserve the immune context while recovering VH/VL families with equine-aware primer coverage.
Naive equine library	One or more non-target-immunized donors with suitable lymphoid or blood-derived material.	Broaden repertoire sampling through donor/source planning and transparent pooling strategy.
Designed / semi-synthetic library	Limited biological material or a project that benefits from defined sequence constraints and controlled diversification.	Specify framework, diversity positions, and display architecture before physical library construction.

Equine Library Construction Workflow

01

Choose the source route.
Define immune, naive, or designed logic. For biological routes, record donor, immune history, source tissue/cells, collection timing, and nucleic-acid status.
02

Plan variable-region recovery or design.
Use available equine sequence information to select primer panels for VH/VL recovery, or define the sequence design and diversification rules for a designed library.
03

Construct the displayed format.
Assemble scFv or Fab architecture with project-selected orientation, linker or constant-domain context, cloning junctions, and reading frame.
04

Create and amplify the physical library.
Clone the repertoire into a compatible display system, recover the library, generate phage, and manage propagation so bottlenecks can be recognized rather than hidden.
05

Release after QC.
Review insert integrity, productive sequence fraction, repertoire-family representation, redundancy, and display competence before optional selection.

Published Data

Workflow for equine PBMC-derived scFv phage display library construction, panning, and recombinant antibody reformatting. (OA Literature) — Fig.1 Schematic workflow of the development of horse-derived recombinant mAbs. ¹

01 / LITERATURE EVIDENCEPublished Data

Equine immune phage-display research has shown how species-specific variable-gene information can be translated into a recombinant antibody library workflow. A horse-specific primer set was designed from available equine immunoglobulin sequence data to amplify rearranged heavy-, kappa-, and lambda-chain variable regions from PBMC-derived cDNA. The amplified repertoires were assembled as scFv libraries, characterized by sequencing, and used for antigen-directed panning; selected scFv sequences were later reformatted for recombinant expression. Importantly, the study also examined repertoire complexity rather than relying on library size alone, using sequence data to describe V-gene representation, CDR length distributions, and clonotype structure. For equine library construction, these observations highlight several practical points: primer design should reflect the known horse V-gene repertoire, both kappa and lambda light-chain diversity may need to be considered, and sequence-based QC can help distinguish physical clone recovery from observed repertoire composition. The reported workflow provides a useful research example of equine-specific repertoire recovery linked to phage display, but its experimental outcomes should be interpreted within the antigens, animals, constructs, and selection conditions used in that study.

Project FAQs

When should an immune, naive, or designed equine library be used?

Use an immune route when the study aims to capture a repertoire shaped by a defined exposure and suitable material exists. Use a naive route for broader equine repertoire sampling without target-specific immune history. A designed or semi-synthetic route is appropriate when deliberate sequence control is more important than direct repertoire capture.

Can existing equine PBMCs be accepted?

Yes, when donor provenance, collection conditions, immune history, storage, quantity, and RNA quality are compatible with the planned workflow. The material is reviewed before primer strategy and expected repertoire coverage are finalized.

How is amplification bias monitored?

Primer grouping, amplicon balance, representative sequencing, and optional deeper repertoire profiling can be used to identify strong family dropout or frequency distortion. The aim is to document and reduce major bias, not to imply perfectly unbiased PCR recovery.

Can multiple horse donors or time points be pooled into one library?

Yes, but pooling should be deliberate. A combined pool can broaden aggregate representation, while separate donor or time-point sublibraries preserve provenance and make biological differences easier to interpret. The pooling strategy is best defined before VH/VL recovery and carried through the QC plan.

What if suitable equine immune material is limited?

A naive, designed, or semi-synthetic route can be considered when direct immune-repertoire capture is not feasible or when deliberate sequence control is preferred. The choice depends on how important equine biological origin is to the research question and how much design freedom is acceptable.

Reference

Rosenfeld, Ronit, et al. "Centaur Antibodies: Engineered Chimeric Equine-Human Recombinant Antibodies." Frontiers in Immunology 13 (2022): 942317. Distributed under Open Access license CC BY, without modification. https://doi.org/10.3389/fimmu.2022.942317.